IVD PRODUCT
MammaTyper®
Molecular subtyping tool for breast cancer based on quantitative mRNA detection
Highlights
CLINICAL VALUE
Molecular subtyping at mRNA level:
Further distinguish the prognosis of breast cancer patients with Luminal type by molecular subtyping at mRNA level.
LRP recurrence risk score:
LRP score can screen patients with low risk of relapse (defined as RS≤25) in a cost-effective way.
PREFERRED POPULATION